INLB (Item 9 Labs) Payments of Debt: $-1.69 Mil (TTM As of Jun. 2023)


INLB Item 9 Labs Corp INLB
12 GF Score
Price $0.00
View Full Analysis

What is Item 9 Labs Payments of Debt?

Item 9 Labs INLB -99.00% 12 Payments of Debt is $-1.69 Mil as of Jun. 2023. GuruFocus rates INLB with a GF Score™ of 12/100.

Item 9 Labs's Payments of Debt for the three months ended in Jun. 2023 was $-0.25 Mil.

Item 9 Labs's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.69 Mil.

Item 9 Labs Payments of Debt Related Terms

Item 9 Labs Payments of Debt Historical Data

* Premium members only.

The historical data trend for Item 9 Labs's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Item 9 Labs Payments of Debt Chart

Item 9 Labs Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.58 -4.58 -3.96

Item 9 Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.07 -0.90 -0.32 -0.21 -0.25
INLB
12GF Score
Item 9 Labs Corp INLB
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Item 9 Labs Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-1.69 Mil mean?
Item 9 Labs (INLB) has a Payments of Debt of $-1.69 Mil as of Jun. 2023. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Item 9 Labs and its competitors.
Is Item 9 Labs' Payments of Debt too high?
Item 9 Labs' current Payments of Debt is $-1.69 Mil. Overall, Item 9 Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Item 9 Labs' Payments of Debt compare to NEPT and CENBF?
Item 9 Labs' Payments of Debt of $-1.69 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Item 9 Labs and its competitors. Item 9 Labs's current Payments of Debt is $-1.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Item 9 Labs stock overvalued right now?
Item 9 Labs (INLB) has a current Payments of Debt of $-1.69 Mil. The current Payments of Debt is $-1.69 Mil. Item 9 Labs' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Item 9 Labs (INLB), the current Payments of Debt is $-1.69 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Item 9 Labs Business Description

Address 2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
12GF Score

Get the complete analysis for INLB

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price